Respiration, ArtificialWAVENCT03697785
Weaning Algorithm for Mechanical VEntilation
A study testing Beacon Care System in people with Respiration, Artificial and Critical Care, run by Royal Brompton & Harefield NHS Foundation Trust at 2 sites in United Kingdom.
Trial summary
To compare the duration of mechanical ventilation and the weaning period between two groups of patients managed with either Standard Care or with mechanical ventilation adjusted according to the Beacon Caresystem, in patients receiving mechanical ventilation for more than 24 hours Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Respiration, Artificial, Critical Care, Respiratory Insufficiency
- What is being tested?
- Beacon Care System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 286 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 24 Sep 2018to 1 Oct 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patient remains on mechanical ventilation at 24 hours following intubation.
- Age > 18 years
- Patient consent or, in the case that the patient is unable, advice from the next of kin or treating physician following understanding and acceptance of oral and written information describing the study.
Who cannot join
- The absence of an arterial catheter for blood sampling at study start.
- Mechanical ventilation initiated for more than 48 hours.
- Medical history of home mechanical ventilation which may lead to prolonged stay in the ICU, including long term oxygen therapy and non-invasive ventilation not associated with sleep apnoea.
- Patients mechanically ventilated in a ventilator mode, and by a ventilator not supported by the Beacon Caresystem on screening.
- Respiratory failure likely requiring extracorporeal support.
- Severe cardiogenic shock likely requiring extracorporeal support.
Show all 12Show fewer
- Severe isolated right heart failure.
- Head trauma or other conditions where intra-cranial pressure may be elevated and tight regulation of arterial CO2 level is paramount.
- Primary (non-overdose related) neurological patients (Glasgow coma score <10, neurologic damage with limited prognosis, stroke hemiplegia).
- End stage liver disease.
- Repeated ICU admission within same hospital admission and/or likely to have prolonged ICU stay with mechanical ventilation (>21 days)
- Pregnancy.
Trial locations and contacts
2 sites in 1 country.
United Kingdom2 sites, 2 recruiting
- Recruiting
Royal Brompton Hospital
London, SW3 6NP
Brijesh V Patel, FRCA PhD, +44 (0)20 7352 8121, b.patel4@rbht.nhs.uk
Cliff Morgan, MBBS FRCA
- Recruiting
Harefield Hospital
Uxbridge, UB9 6JH
Brijesh Patel
Alex Rosenberg
About this study
Official title: Weaning Algorithm for Mechanical VEntilation (WAVE Study): A Randomised Control Trial Comparing an Open-loop Decision Support System Versus Routine Care for Weaning From Mechanical Ventilation in the Cardiothoracic Intensive Care Unit
To compare the duration of mechanical ventilation and the weaning period between two groups of patients managed with either Standard Care or with mechanical ventilation adjusted according to the Beacon Caresystem, in patients receiving mechanical ventilation for more than 24 hours
Read the detailed description
Patients admitted to the intensive care unit typically receive invasive mechanical ventilatory support when they are critically ill. Whilst mechanical ventilation is a life-saving intervention, it can also lead to deleterious consequences and cause lung damage (known as ventilator-associated lung injury) if not implemented carefully. Hence, reducing the duration of mechanical ventilation should reduce complications such as ventilator-associated lung injury, ventilator-acquired pneumonia, respiratory and skeletal muscle wasting, and patient discomfort, leading to decreasing mortality and economic costs etc. Importantly, prolonged weaning perpetuates these complications which further increase the duration of mechanical ventilation thereby creating a viscous cycle leading to greater morbidity and mortality.
The availability and education of intensive care unit (ICU) staff are important considerations in minimizing the duration of mechanical ventilation through weaning protocols. It is common practice that the attending physician decides upon patient's therapy and ventilatory management according to recommendations. This usually occurs as part of medical rounds. In addition, nurses often manage the weaning of patients from mechanical ventilation either by following attending physicians' instructions or local guidelines protocols. Such protocol-directed, nurse-driven weaning has been shown to reduce the duration of mechanical ventilation. However, it has been shown that the quantity and quality of nursing are important factors if duration is to be reduced.
Several decision support systems have been developed to help select optimal mechanical ventilator strategies. Those finding their way into routine clinical practice have typically been based on clinical guidelines or rules rather than detailed physiological description of the individual patient. A recent Cochrane review of weaning trials with these systems concluded that use of these systems may reduce duration of weaning, but pointed out that many of these trials are based on patients that are 'simple to wean'. Such patients are usually less complex, without lung pathology, and ventilated for less than 48 hours. However, there is a need to develop and validate protocolised systems that utilize a more detailed physiological description of individual patients to aid in the management of complex patients ventilated for longer durations.
The Beacon Caresystem is a model-based decision support system using mathematical models tuned to the individual patient's physiology to advise on appropriate ventilator settings. Personalised approaches using individual patient description may be particularly advantageous in complex patients, including those who are difficult to mechanically ventilate and wean; precisely those where previous systems have not been sufficiently evaluated. The Beacon Caresystem is a commercial version of the system previously known as INVENT, which has been retrospectively evaluated in post-operative cardiac patients and patients with severe lung disease, and prospectively evaluated in advising on the correct level of inspiratory oxygen. Furthermore, studies are near completion showing that the system provides safe and appropriate advice on inspired oxygen, respiratory frequency, tidal volume, pressure support/control and positive end expiratory pressure (PEEP) in a wide variety of patients ranging from patients with severe respiratory failure to patients close to extubation (unpublished data). However, previous and ongoing studies with the Beacon Caresystem have focused on safety and efficacy of advice under limited time periods, and have not focused on weaning from mechanical ventilation.
The core of the Beacon Caresystem is a set of physiological models including pulmonary gas exchange, acid-base chemistry, lung mechanics, and respiratory drive. The Beacon Caresystem tunes these models to the individual patient such that they describe accurately current measurements. Once tuned, the models are used by the system to simulate the effects of changing ventilator settings. The results of these simulations are then used to calculate the clinical benefit of changing ventilator settings by balancing the competing goals of mechanical ventilation. For example, an increased inspiratory volume will reduce an acidosis of the blood while detrimentally increasing lung pressure. Appropriate ventilator settings therefore imply a balance between the preferred value of pH weighted against the preferred value of lung pressure. A number of these balances exist, and the system weighs these, calculating a total score for the patient for any possible ventilation strategy. The system then calculates advice as to changes in ventilator settings so to as improve this score. The Beacon Caresystem functions as an "open loop" system. This means that the advice provided by the system is presented to the clinician. The ventilator settings are then changed by the clinician, and the patient's physiological response to these changes is automatically used by the system to re-tune the models and repeat the process of generating new advice.
In calculating appropriate advice, selecting the correct level of positive end expiratory pressure (PEEP) is particularly challenging. The nature of the challenge is however, very different depending upon the presence or type of lung abnormality, and the function of the heart. Patients with severe lung abnormalities such as acute respiratory distress syndrome (ARDS), which often result in small, stiff lungs, are often in control ventilation mode with little or no spontaneous breathing. For these patients, PEEP is often increased to try to recruit units of the lung which are collapsed. This can be difficult, as increasing PEEP may result in elevated lung pressure and hence an increased the risk of lung injury, incomplete expiration and air trapping, and haemodynamic compromise, especially in those with heart failure.
Patients in support ventilation modes have some degree of spontaneous breathing, and the correct selection of PEEP therefore includes different criteria. It is important that these patients be weaned as quickly as possible, and PEEP is reduced as part of that process. If the setting of PEEP is too low, there is a risk of increased resistance to airflow with added respiratory work and consequent risk of respiratory muscle fatigue. If the patient has intrinsic PEEP due to dynamic hyperinflation, reducing PEEP below the level of intrinsic PEEP would also cause increased inspiratory threshold load on the respiratory muscles, and potential muscle fatigue. If PEEP is too high the respiratory muscle fibres may be shortened reducing their pressure generating capacity and endurance thus increasing the risk of respiratory muscle fatigue. Changing pressure support may help to work against an additional workload, as in cases of increased resistance or autoPEEP, whilst correct PEEP may counter the additional load.
The above factors are taken into account by the physiological models of the Beacon Caresystem, and patient specific advice is also provided on PEEP. In addition to providing advice on changing individual ventilator settings, the system also advises on when measurement of arterial blood gas is necessary, when it is important to change ventilator mode, and when a spontaneous breathing test is passed, and as such extubation should be considered.
However, previous and ongoing studies with the Beacon Caresystem have focused on safety and efficacy of advice under limited time periods, and have not focused on weaning from mechanical ventilation. A current study is underway in a French hospital (Clinical Trials number: NCT02842944), and at a UK hospital (IRAS 226610), to assess the benefit of the Beacon Caresystem in general medical intensive care patients. However, as mechanical ventilation therapy can vary with different patient populations it is important that investigation of the effects of use of the Beacon system be studied in numerous different clinical situations. In contrast to other studies, this study will investigate the effects of the Beacon Caresystem in ICU patients with primary cardio-thoracic disease, with these patients representing a substantial sub group of all ICU patients worldwide.
The purpose of this study is to compare mechanical ventilation following advice from the Beacon Caresystem to that of routine care in cardio-thoracic ICU patients from the start of requiring invasive mechanical ventilation until ICU discharge or death. The Beacon Caresystem will be compared to routine care to investigate whether use of the system results in similar care or reduced time for weaning from mechanical ventilation.
- Conditions
- Respiration, Artificial, Critical Care, Respiratory Insufficiency, Intensive Care (ICU) Myopathy, Mechanical Ventilation Complication
- Being tested
- Beacon Care System
- Keywords
- weaning, cardiothoracic, mechanical ventilation, intensive care, critical care, beacon caresystem
- Medical subject headings
- Respiratory Aspiration, Respiratory Insufficiency, Muscular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Beacon Care SystemDevice
Beacon has been developed by Mermaid Care in Denmark. BEACON is a critical care ventilation assist system (http://beaconcaresystem.com/beacon-5/), which potentially enables better ventilation strategies and a more efficient patient care workflow. As an add-on to standard ventilation systems it provides ventilation recommendations 24/7 based on non-stop, personalised monitoring/diagnostics of patients. Based on unique mathematical algorithms and physiological models, it recommends changes in ventilation settings, supporting the critical decision-making processes.
| Study group | Role | What they receive |
|---|---|---|
| Beacon Caresystem with weaning advice | Experimental | Beacon care system set up to give weaning advice and options to accept or reject advice. Receives: Device: Beacon Care System |
| Beacon Caresystem for monitoring only | Other | Beacon care system attached but only for data collection purposes. No advice will be given. Receives: Device: Beacon Care System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Duration of mechanical ventilation
Defined as the time from the start of mechanical ventilation, defined as either the time of intubation in the ICU (or the time of admission to the ICU following previous intubation for surgery) and until successful extubation, with successful extubation defined as ≥48 hours of unassisted spontaneous breathing after extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Secondary outcomes (47)
Duration of mechanical ventilation following randomisation
Defined as the time from randomisation and until successful extubation, with successful extubation defined as ≥48 hours of unassisted spontaneous breathing after extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Time from control mode to support mode
Defined as the time following randomisation, from initiation of control modes of ventilation and until initiation of support modes of ventilation.
Measured: Until the date of discharge from ICU, up to 12 months.
Time from support mode to successful extubation
Defined as the time following randomisation, from initiation of support modes of ventilation and until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Number of changes in ventilator settings per day
Defined as the daily registered number of changes to ventilator settings from patient randomization until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Time to first spontaneous breathing test (SBT)
Defined as the time from randomization to the first performed SBT.
Measured: Until the date of discharge from ICU, up to 12 months.
Time to first successful SBT
Defined as the time from randomization to the first successful SBT.
Measured: Until the date of discharge from ICU, up to 12 months.
Time to first extubation
Defined as the time from randomization to the first extubation attempt.
Measured: Until the date of discharge from ICU, up to 12 months.
% of time in control mode ventilation
Defined as the time from randomization spent in controlled modes of mechanical ventilation in percent of duration of mechanical ventilation
Measured: Until the date of discharge from ICU, up to 12 months.
% of time in support mode ventilation
Defined as the time from randomisation which is spent in support modes of mechanical ventilation in percent of duration of mechanical ventilation
Measured: Until the date of discharge from ICU, up to 12 months.
Time to first period trachemask
Defined as the time of randomisation to the point of trachemask initiation.
Measured: Until the date of discharge from ICU, up to 12 months.
Use of neuromuscular blockading agents
Defined as the cumulative use of neuromuscular blockading agents from randomization until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Use of sedatives
Defined as the cumulative use of sedative drugs from randomization until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Number of intubation free days
Defined as the number of days without intubation from randomization until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Number of reintubations
Defined as the number of reintubations following extubation from randomization until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Number of tracheostomies
Defined as the number of patients having tracheostomy performed from randomization until successful extubation or protocol end.
Measured: Until the date of discharge from ICU, up to 12 months.
Number of patients on prolonged mechanical ventilation
Defined as the number of patients on mechanical ventilation ongoing for more than 21 days after initial intubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Number and types of adverse events related to mechanical ventilation
Defined as the incidence of adverse events directly related to mechanical ventilation
Measured: Until the date of discharge from ICU, up to 12 months.
Frequency of accepting Beacon care system advice
Number of times and the reasons the advice from the Beacon system is overridden and not accepted by a treating clinician.
Measured: Until the date of discharge from ICU, up to 12 months.
ICU mortality
defined as the mortality from randomization and until death or ICU discharge.
Measured: Until the date of discharge from ICU, up to 12 months.
Hospital mortality
defined as the mortality from randomization and until death or hospital discharge.
Measured: Until the date of discharge from ICU, up to 12 months.
Length of ICU stay
defined as the duration of ICU admission from randomization to ICU discharge
Measured: Until the date of discharge from ICU, up to 12 months.
Length of hospital stay
defined as the duration of hospital admission from randomization to hospital discharge
Measured: Until the date of discharge from hospital, up to 12 months.
Time to first mobilization
Defined as the time from randomisation until first mobilization, e.g. sitting on the edge of the bed, standing up and marching on the spot
Measured: Until the date of discharge from ICU, up to 12 months.
Time to independent mobilization
Defined as the time from randomisation until regaining independency, e.g. able to drink/eat or comb hair.
Measured: Until the date of discharge from ICU, up to 12 months.
Daily patient physiological blood gas status
Defined as daily PaO2/FiO2 from randomization until successful extubation.
Measured: Until the date of discharge from ICU, up to 12 months.
Changes in Oxygenation Index
defined as daily averages of oxygenation index (Oxygen Index (OI) = (FiO2 x Mean Alveaolr Pressure x 100) / PaO2
Measured: Until the date of discharge from ICU, up to 12 months.
Changes in anatomical dead space volume
defined as daily changes in dead space volume as continuously measured by the Beacon system.
Measured: Until the date of discharge from ICU, up to 12 months.
Changes in pulmonary shunt fraction
defined as daily changes in pulmonary shunt fraction as continuously measured by the Beacon system.
Measured: Until the date of discharge from ICU, up to 12 months.
Changes in end-tidal end-tidal CO2 fraction (FE'CO2)
defined as daily changes in end-tidal CO2 fraction as continuously measured by the Beacon system.
Measured: Until the date of discharge from ICU, up to 12 months.
Changes in pulmonary mechanics
defined as daily changes in respiratory system compliance as continuously measured by the Beacon system.
Measured: Until the date of discharge from ICU, up to 12 months.
Changes in metabolism
defined as daily changes in resting energy expenditure as continuously measured by the Beacon system.
Measured: Until the date of discharge from ICU, up to 12 months.
ICU/hospital lung imaging in relation to prolonged ventilation
e.g. chest CT injury indices.
Measured: Until the date of discharge from hospital, up to 12 months.
Timed-up-and-go at day 10 (or first mobilisation) and ICU/Hospital Discharge
Timed-up-and-go at day 10 (or first mobilisation) and ICU/Hospital Discharge
Measured: Until the date of discharge from hospital, up to 12 months.
Sit to stand at day 10 (or first mobilisation) and ICU/Hospital Discharge
Sit to stand at day 10 (or first mobilisation) and ICU/Hospital Discharge
Measured: Until the date of discharge from hospital, up to 12 months.
Chelsea Critical Care Physiotherapy Assessment score (CPAx) trajectory
Chelsea Critical Care Physiotherapy Assessment score (CPAx) trajectory (performed every 72 hours)
Measured: Until the date of discharge from hospital, up to 12 months.
Barthel index at hospital discharge
Barthel index at hospital discharge
Measured: Until the date of discharge from hospital, up to 12 months.
6-minute walk test at hospital discharge
6-minute walk test at hospital discharge
Measured: Until the date of discharge from hospital, up to 12 months.
3-month +/- 6-month +/- 1-year ICU follow-up lung imaging and function in relation to prolonged ventilation
ICU follow-up lung imaging and function in relation to prolonged ventilation (as per current clinical protocol i.e. if clinically indicated, which may include pulmonary function tests, CT imaging).
Measured: Until the date of discharge from hospital, up to 24 months.
Sf-36 Health Related Quality of life (patient and carers)
-Sf-36 Health Related Quality of life (patient and carers)
Measured: Until one year after hospital discharge, up to 24 months.
EQ-5D-5L
EQ-5D-5L
Measured: Until one year after hospital discharge, up to 24 months.
St George's Respiratory Questionnaire
St George's Respiratory Questionnaire
Measured: Until one year after hospital discharge, up to 24 months.
mini Mental State examination
mini Mental State examination
Measured: Until one year after hospital discharge, up to 24 months.
PTSS-14
PTSS-14
Measured: Until one year after hospital discharge, up to 24 months.
Hospital Anxiety and Depression Scale (HADS)
Hospital Anxiety and Depression Scale (HADS)
Measured: Until one year after hospital discharge, up to 24 months.
Return to work rates e.g. W&SAS (patient and carers)
Return to work rates e.g. W\&SAS (patient and carers)
Measured: Until one year after hospital discharge, up to 24 months.
Primary and Secondary care utilisation
Primary and Secondary care utilisation
Measured: Until one year after hospital discharge, up to 36 months.
6-minute walk test
6-minute walk test
Measured: Until one year after hospital discharge, up to 24 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Oct 2018
- Study start24 Sep 2018
- Primary completion1 Oct 2021 (estimated)
- Study completion1 Oct 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (28)Papers the sponsor has linked to this study.
- Other trials for Respiration, ArtificialStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 286 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Collaborators
- Mermaid Care A/S, Aalborg University, Imperial College London
- Responsible party
- Sponsor
- Investigators
- Brijesh Patel, MBBS PhD, Principal investigator, Royal Brompton & Harefield NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03697785
- Sponsor's protocol ID
- REC Reference: 18/LO/0282
- Other IDs
- 239144
- Acronym
- WAVE
- Status last verified
- Oct 2018
- First submitted
- 2 Oct 2018
- Last updated
- 5 Oct 2018
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801.
PubMed 10793162Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
PubMed 26903337Blackwood B, Alderdice F, Burns K, Cardwell C, Lavery G, O'Halloran P. Use of weaning protocols for reducing duration of mechanical ventilation in critically ill adult patients: Cochrane systematic review and meta-analysis. BMJ. 2011 Jan 13;342:c7237. doi: 10.1136/bmj.c7237.
PubMed 21233157Danckers M, Grosu H, Jean R, Cruz RB, Fidellaga A, Han Q, Awerbuch E, Jadhav N, Rose K, Khouli H. Nurse-driven, protocol-directed weaning from mechanical ventilation improves clinical outcomes and is well accepted by intensive care unit physicians. J Crit Care. 2013 Aug;28(4):433-41. doi: 10.1016/j.jcrc.2012.10.012. Epub 2012 Dec 21.
PubMed 23265291Thorens JB, Kaelin RM, Jolliet P, Chevrolet JC. Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease. Crit Care Med. 1995 Nov;23(11):1807-15. doi: 10.1097/00003246-199511000-00004.
PubMed 7587255Lellouche F, Mancebo J, Jolliet P, Roeseler J, Schortgen F, Dojat M, Cabello B, Bouadma L, Rodriguez P, Maggiore S, Reynaert M, Mersmann S, Brochard L. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006 Oct 15;174(8):894-900. doi: 10.1164/rccm.200511-1780OC. Epub 2006 Jul 13.
PubMed 16840741Sulemanji D, Marchese A, Garbarini P, Wysocki M, Kacmarek RM. Adaptive support ventilation: an appropriate mechanical ventilation strategy for acute respiratory distress syndrome? Anesthesiology. 2009 Oct;111(4):863-70. doi: 10.1097/ALN.0b013e3181b55f8f.
PubMed 19741490Rose L, Schultz MJ, Cardwell CR, Jouvet P, McAuley DF, Blackwood B. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children: a cochrane systematic review and meta-analysis. Crit Care. 2015 Feb 24;19(1):48. doi: 10.1186/s13054-015-0755-6.
PubMed 25887887Rees SE, Allerod C, Murley D, Zhao Y, Smith BW, Kjaergaard S, Thorgaard P, Andreassen S. Using physiological models and decision theory for selecting appropriate ventilator settings. J Clin Monit Comput. 2006 Dec;20(6):421-9. doi: 10.1007/s10877-006-9049-5. Epub 2006 Sep 15.
PubMed 16977430Rees SE, Karbing DS. Determining the appropriate model complexity for patient-specific advice on mechanical ventilation. Biomed Tech (Berl). 2017 Apr 1;62(2):183-198. doi: 10.1515/bmt-2016-0061.
PubMed 27930361Allerod C, Rees SE, Rasmussen BS, Karbing DS, Kjaergaard S, Thorgaard P, Andreassen S. A decision support system for suggesting ventilator settings: retrospective evaluation in cardiac surgery patients ventilated in the ICU. Comput Methods Programs Biomed. 2008 Nov;92(2):205-12. doi: 10.1016/j.cmpb.2008.07.001.
PubMed 18715670Karbing DS, Allerod C, Thomsen LP, Espersen K, Thorgaard P, Andreassen S, Kjaergaard S, Rees SE. Retrospective evaluation of a decision support system for controlled mechanical ventilation. Med Biol Eng Comput. 2012 Jan;50(1):43-51. doi: 10.1007/s11517-011-0843-y. Epub 2011 Nov 22.
PubMed 22105216Karbing DS, Allerod C, Thorgaard P, Carius AM, Frilev L, Andreassen S, Kjaergaard S, Rees SE. Prospective evaluation of a decision support system for setting inspired oxygen in intensive care patients. J Crit Care. 2010 Sep;25(3):367-74. doi: 10.1016/j.jcrc.2009.12.013. Epub 2010 Feb 10.
PubMed 20149586Powers SK, Wiggs MP, Sollanek KJ, Smuder AJ. Ventilator-induced diaphragm dysfunction: cause and effect. Am J Physiol Regul Integr Comp Physiol. 2013 Sep;305(5):R464-77. doi: 10.1152/ajpregu.00231.2013. Epub 2013 Jul 10.
PubMed 23842681MacIntyre NR, Cheng KC, McConnell R. Applied PEEP during pressure support reduces the inspiratory threshold load of intrinsic PEEP. Chest. 1997 Jan;111(1):188-93. doi: 10.1378/chest.111.1.188.
PubMed 8996015
Study at a glance
From the registry record, last updated by the sponsor on 5 Oct 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Weaning Algorithm for Mechanical VEntilation (WAVE Study): A Randomised Control Trial Comparing an Open-loop Decision Support System Versus Routine Care for Weaning From Mechanical Ventilation in the Cardiothoracic Intensive Care Unit
- ClinicalTrials.gov ID
- NCT03697785
- Acronym / sponsor ID
- WAVE / REC Reference: 18/LO/0282
- Conditions
- Respiration, Artificial, Critical Care, Respiratory Insufficiency, Intensive Care (ICU) Myopathy, Mechanical Ventilation Complication
- Keywords
- weaning, cardiothoracic, mechanical ventilation, intensive care, critical care, beacon caresystem
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 286 participants (estimated)
- Lead sponsor
- Royal Brompton & Harefield NHS Foundation TrustUniversity, hospital or other
- Collaborators
- Mermaid Care A/S, Aalborg University, Imperial College London
- Study start
- 24 Sep 2018 (actual)
- Primary completion
- 1 Oct 2021 (estimated)
- Study completion
- 1 Oct 2021 (estimated)
- First posted
- 5 Oct 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compare the duration of mechanical ventilation and the weaning period between two groups of patients managed with either Standard Care or with mechanical ventilation adjusted according to the Beacon Caresystem, in patients receiving mechanical ventilation for more than 24 hours
Detailed description
Patients admitted to the intensive care unit typically receive invasive mechanical ventilatory support when they are critically ill. Whilst mechanical ventilation is a life-saving intervention, it can also lead to deleterious consequences and cause lung damage (known as ventilator-associated lung injury) if not implemented carefully. Hence, reducing the duration of mechanical ventilation should reduce complications such as ventilator-associated lung injury, ventilator-acquired pneumonia, respiratory and skeletal muscle wasting, and patient discomfort, leading to decreasing mortality and economic costs etc. Importantly, prolonged weaning perpetuates these complications which further increase the duration of mechanical ventilation thereby creating a viscous cycle leading to greater morbidity and mortality.
The availability and education of intensive care unit (ICU) staff are important considerations in minimizing the duration of mechanical ventilation through weaning protocols. It is common practice that the attending physician decides upon patient's therapy and ventilatory management according to recommendations. This usually occurs as part of medical rounds. In addition, nurses often manage the weaning of patients from mechanical ventilation either by following attending physicians' instructions or local guidelines protocols. Such protocol-directed, nurse-driven weaning has been shown to reduce the duration of mechanical ventilation. However, it has been shown that the quantity and quality of nursing are important factors if duration is to be reduced.
Several decision support systems have been developed to help select optimal mechanical ventilator strategies. Those finding their way into routine clinical practice have typically been based on clinical guidelines or rules rather than detailed physiological description of the individual patient. A recent Cochrane review of weaning trials with these systems concluded that use of these systems may reduce duration of weaning, but pointed out that many of these trials are based on patients that are 'simple to wean'. Such patients are usually less complex, without lung pathology, and ventilated for less than 48 hours. However, there is a need to develop and validate protocolised systems that utilize a more detailed physiological description of individual patients to aid in the management of complex patients ventilated for longer durations.
The Beacon Caresystem is a model-based decision support system using mathematical models tuned to the individual patient's physiology to advise on appropriate ventilator settings. Personalised approaches using individual patient description may be particularly advantageous in complex patients, including those who are difficult to mechanically ventilate and wean; precisely those where previous systems have not been sufficiently evaluated. The Beacon Caresystem is a commercial version of the system previously known as INVENT, which has been retrospectively evaluated in post-operative cardiac patients and patients with severe lung disease, and prospectively evaluated in advising on the correct level of inspiratory oxygen. Furthermore, studies are near completion showing that the system provides safe and appropriate advice on inspired oxygen, respiratory frequency, tidal volume, pressure support/control and positive end expiratory pressure (PEEP) in a wide variety of patients ranging from patients with severe respiratory failure to patients close to extubation (unpublished data). However, previous and ongoing studies with the Beacon Caresystem have focused on safety and efficacy of advice under limited time periods, and have not focused on weaning from mechanical ventilation.
The core of the Beacon Caresystem is a set of physiological models including pulmonary gas exchange, acid-base chemistry, lung mechanics, and respiratory drive. The Beacon Caresystem tunes these models to the individual patient such that they describe accurately current measurements. Once tuned, the models are used by the system to simulate the effects of changing ventilator settings. The results of these simulations are then used to calculate the clinical benefit of changing ventilator settings by balancing the competing goals of mechanical ventilation. For example, an increased inspiratory volume will reduce an acidosis of the blood while detrimentally increasing lung pressure. Appropriate ventilator settings therefore imply a balance between the preferred value of pH weighted against the preferred value of lung pressure. A number of these balances exist, and the system weighs these, calculating a total score for the patient for any possible ventilation strategy. The system then calculates advice as to changes in ventilator settings so to as improve this score. The Beacon Caresystem functions as an "open loop" system. This means that the advice provided by the system is presented to the clinician. The ventilator settings are then changed by the clinician, and the patient's physiological response to these changes is automatically used by the system to re-tune the models and repeat the process of generating new advice.
In calculating appropriate advice, selecting the correct level of positive end expiratory pressure (PEEP) is particularly challenging. The nature of the challenge is however, very different depending upon the presence or type of lung abnormality, and the function of the heart. Patients with severe lung abnormalities such as acute respiratory distress syndrome (ARDS), which often result in small, stiff lungs, are often in control ventilation mode with little or no spontaneous breathing. For these patients, PEEP is often increased to try to recruit units of the lung which are collapsed. This can be difficult, as increasing PEEP may result in elevated lung pressure and hence an increased the risk of lung injury, incomplete expiration and air trapping, and haemodynamic compromise, especially in those with heart failure.
Patients in support ventilation modes have some degree of spontaneous breathing, and the correct selection of PEEP therefore includes different criteria. It is important that these patients be weaned as quickly as possible, and PEEP is reduced as part of that process. If the setting of PEEP is too low, there is a risk of increased resistance to airflow with added respiratory work and consequent risk of respiratory muscle fatigue. If the patient has intrinsic PEEP due to dynamic hyperinflation, reducing PEEP below the level of intrinsic PEEP would also cause increased inspiratory threshold load on the respiratory muscles, and potential muscle fatigue. If PEEP is too high the respiratory muscle fibres may be shortened reducing their pressure generating capacity and endurance thus increasing the risk of respiratory muscle fatigue. Changing pressure support may help to work against an additional workload, as in cases of increased resistance or autoPEEP, whilst correct PEEP may counter the additional load.
The above factors are taken into account by the physiological models of the Beacon Caresystem, and patient specific advice is also provided on PEEP. In addition to providing advice on changing individual ventilator settings, the system also advises on when measurement of arterial blood gas is necessary, when it is important to change ventilator mode, and when a spontaneous breathing test is passed, and as such extubation should be considered.
However, previous and ongoing studies with the Beacon Caresystem have focused on safety and efficacy of advice under limited time periods, and have not focused on weaning from mechanical ventilation. A current study is underway in a French hospital (Clinical Trials number: NCT02842944), and at a UK hospital (IRAS 226610), to assess the benefit of the Beacon Caresystem in general medical intensive care patients. However, as mechanical ventilation therapy can vary with different patient populations it is important that investigation of the effects of use of the Beacon system be studied in numerous different clinical situations. In contrast to other studies, this study will investigate the effects of the Beacon Caresystem in ICU patients with primary cardio-thoracic disease, with these patients representing a substantial sub group of all ICU patients worldwide.
The purpose of this study is to compare mechanical ventilation following advice from the Beacon Caresystem to that of routine care in cardio-thoracic ICU patients from the start of requiring invasive mechanical ventilation until ICU discharge or death. The Beacon Caresystem will be compared to routine care to investigate whether use of the system results in similar care or reduced time for weaning from mechanical ventilation.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Beacon Caresystem with weaning advice | Experimental | Device: Beacon Care SystemBeacon care system set up to give weaning advice and options to accept or reject advice. |
| Beacon Caresystem for monitoring only | Other | Device: Beacon Care SystemBeacon care system attached but only for data collection purposes. No advice will be given. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patient remains on mechanical ventilation at 24 hours following intubation.
- Age > 18 years
- Patient consent or, in the case that the patient is unable, advice from the next of kin or treating physician following understanding and acceptance of oral and written information describing the study.
Key exclusion criteria (12 listed)
- The absence of an arterial catheter for blood sampling at study start.
- Mechanical ventilation initiated for more than 48 hours.
- Medical history of home mechanical ventilation which may lead to prolonged stay in the ICU, including long term oxygen therapy and non-invasive ventilation not associated with sleep apnoea.
- Patients mechanically ventilated in a ventilator mode, and by a ventilator not supported by the Beacon Caresystem on screening.
- Respiratory failure likely requiring extracorporeal support.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Beacon Care SystemBeacon has been developed by Mermaid Care in Denmark. BEACON is a critical care ventilation assist system (http://beaconcaresystem.com/beacon-5/), which potentially enables better ventilation strategies and a more efficient patient care workflow. As an add-on to standard ventilation systems it provides ventilation recommendations 24/7 based on non-stop, personalised monitoring/diagnostics of patients. Based on unique mathematical algorithms and physiological models, it recommends changes in ventilation settings, supporting the critical decision-making processes. | Device | Beacon Caresystem for monitoring only, Beacon Caresystem with weaning advice |
Primary outcome
Duration of mechanical ventilation
Time frame: Until the date of discharge from ICU, up to 12 months.
Defined as the time from the start of mechanical ventilation, defined as either the time of intubation in the ICU (or the time of admission to the ICU following previous intubation for surgery) and until successful extubation, with successful extubation defined as ≥48 hours of unassisted spontaneous breathing after extubation.
47 secondary outcomes
Duration of mechanical ventilation following randomisation
Time frame: Until the date of discharge from ICU, up to 12 months.
Time from control mode to support mode
Time frame: Until the date of discharge from ICU, up to 12 months.
Time from support mode to successful extubation
Time frame: Until the date of discharge from ICU, up to 12 months.
Number of changes in ventilator settings per day
Time frame: Until the date of discharge from ICU, up to 12 months.
Time to first spontaneous breathing test (SBT)
Time frame: Until the date of discharge from ICU, up to 12 months.
Time to first successful SBT
Time frame: Until the date of discharge from ICU, up to 12 months.
Time to first extubation
Time frame: Until the date of discharge from ICU, up to 12 months.
% of time in control mode ventilation
Time frame: Until the date of discharge from ICU, up to 12 months.
% of time in support mode ventilation
Time frame: Until the date of discharge from ICU, up to 12 months.
Time to first period trachemask
Time frame: Until the date of discharge from ICU, up to 12 months.
Use of neuromuscular blockading agents
Time frame: Until the date of discharge from ICU, up to 12 months.
Use of sedatives
Time frame: Until the date of discharge from ICU, up to 12 months.
Number of intubation free days
Time frame: Until the date of discharge from ICU, up to 12 months.
Number of reintubations
Time frame: Until the date of discharge from ICU, up to 12 months.
Number of tracheostomies
Time frame: Until the date of discharge from ICU, up to 12 months.
Number of patients on prolonged mechanical ventilation
Time frame: Until the date of discharge from ICU, up to 12 months.
Number and types of adverse events related to mechanical ventilation
Time frame: Until the date of discharge from ICU, up to 12 months.
Frequency of accepting Beacon care system advice
Time frame: Until the date of discharge from ICU, up to 12 months.
ICU mortality
Time frame: Until the date of discharge from ICU, up to 12 months.
Hospital mortality
Time frame: Until the date of discharge from ICU, up to 12 months.
Length of ICU stay
Time frame: Until the date of discharge from ICU, up to 12 months.
Length of hospital stay
Time frame: Until the date of discharge from hospital, up to 12 months.
Time to first mobilization
Time frame: Until the date of discharge from ICU, up to 12 months.
Time to independent mobilization
Time frame: Until the date of discharge from ICU, up to 12 months.
Daily patient physiological blood gas status
Time frame: Until the date of discharge from ICU, up to 12 months.
Changes in Oxygenation Index
Time frame: Until the date of discharge from ICU, up to 12 months.
Changes in anatomical dead space volume
Time frame: Until the date of discharge from ICU, up to 12 months.
Changes in pulmonary shunt fraction
Time frame: Until the date of discharge from ICU, up to 12 months.
Changes in end-tidal end-tidal CO2 fraction (FE'CO2)
Time frame: Until the date of discharge from ICU, up to 12 months.
Changes in pulmonary mechanics
Time frame: Until the date of discharge from ICU, up to 12 months.
Changes in metabolism
Time frame: Until the date of discharge from ICU, up to 12 months.
ICU/hospital lung imaging in relation to prolonged ventilation
Time frame: Until the date of discharge from hospital, up to 12 months.
Timed-up-and-go at day 10 (or first mobilisation) and ICU/Hospital Discharge
Time frame: Until the date of discharge from hospital, up to 12 months.
Sit to stand at day 10 (or first mobilisation) and ICU/Hospital Discharge
Time frame: Until the date of discharge from hospital, up to 12 months.
Chelsea Critical Care Physiotherapy Assessment score (CPAx) trajectory
Time frame: Until the date of discharge from hospital, up to 12 months.
Barthel index at hospital discharge
Time frame: Until the date of discharge from hospital, up to 12 months.
6-minute walk test at hospital discharge
Time frame: Until the date of discharge from hospital, up to 12 months.
3-month +/- 6-month +/- 1-year ICU follow-up lung imaging and function in relation to prolonged ventilation
Time frame: Until the date of discharge from hospital, up to 24 months.
Sf-36 Health Related Quality of life (patient and carers)
Time frame: Until one year after hospital discharge, up to 24 months.
EQ-5D-5L
Time frame: Until one year after hospital discharge, up to 24 months.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Oct 2018.
- Background: PubMed 10793162Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801.
- Background: PubMed 26903337Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
- Background: PubMed 21233157Blackwood B, Alderdice F, Burns K, Cardwell C, Lavery G, O'Halloran P. Use of weaning protocols for reducing duration of mechanical ventilation in critically ill adult patients: Cochrane systematic review and meta-analysis. BMJ. 2011 Jan 13;342:c7237. doi: 10.1136/bmj.c7237.
- Background: PubMed 23265291Danckers M, Grosu H, Jean R, Cruz RB, Fidellaga A, Han Q, Awerbuch E, Jadhav N, Rose K, Khouli H. Nurse-driven, protocol-directed weaning from mechanical ventilation improves clinical outcomes and is well accepted by intensive care unit physicians. J Crit Care. 2013 Aug;28(4):433-41. doi: 10.1016/j.jcrc.2012.10.012. Epub 2012 Dec 21.
- Background: PubMed 7587255Thorens JB, Kaelin RM, Jolliet P, Chevrolet JC. Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease. Crit Care Med. 1995 Nov;23(11):1807-15. doi: 10.1097/00003246-199511000-00004.
- Background: PubMed 16840741Lellouche F, Mancebo J, Jolliet P, Roeseler J, Schortgen F, Dojat M, Cabello B, Bouadma L, Rodriguez P, Maggiore S, Reynaert M, Mersmann S, Brochard L. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006 Oct 15;174(8):894-900. doi: 10.1164/rccm.200511-1780OC. Epub 2006 Jul 13.
- Background: PubMed 19741490Sulemanji D, Marchese A, Garbarini P, Wysocki M, Kacmarek RM. Adaptive support ventilation: an appropriate mechanical ventilation strategy for acute respiratory distress syndrome? Anesthesiology. 2009 Oct;111(4):863-70. doi: 10.1097/ALN.0b013e3181b55f8f.
- Background: PubMed 25887887Rose L, Schultz MJ, Cardwell CR, Jouvet P, McAuley DF, Blackwood B. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children: a cochrane systematic review and meta-analysis. Crit Care. 2015 Feb 24;19(1):48. doi: 10.1186/s13054-015-0755-6.
- Background: PubMed 16977430Rees SE, Allerod C, Murley D, Zhao Y, Smith BW, Kjaergaard S, Thorgaard P, Andreassen S. Using physiological models and decision theory for selecting appropriate ventilator settings. J Clin Monit Comput. 2006 Dec;20(6):421-9. doi: 10.1007/s10877-006-9049-5. Epub 2006 Sep 15.
- Background: PubMed 27930361Rees SE, Karbing DS. Determining the appropriate model complexity for patient-specific advice on mechanical ventilation. Biomed Tech (Berl). 2017 Apr 1;62(2):183-198. doi: 10.1515/bmt-2016-0061.
- Background: PubMed 18715670Allerod C, Rees SE, Rasmussen BS, Karbing DS, Kjaergaard S, Thorgaard P, Andreassen S. A decision support system for suggesting ventilator settings: retrospective evaluation in cardiac surgery patients ventilated in the ICU. Comput Methods Programs Biomed. 2008 Nov;92(2):205-12. doi: 10.1016/j.cmpb.2008.07.001.
- Background: PubMed 22105216Karbing DS, Allerod C, Thomsen LP, Espersen K, Thorgaard P, Andreassen S, Kjaergaard S, Rees SE. Retrospective evaluation of a decision support system for controlled mechanical ventilation. Med Biol Eng Comput. 2012 Jan;50(1):43-51. doi: 10.1007/s11517-011-0843-y. Epub 2011 Nov 22.
- Individual participant dataSharing planned: Undecided
Related trials for Respiration, Artificial
Not yet recruiting
Miniature In-line Respirator
Brain Death, Respiration, Artificial
Not yet recruitingObservational study
Development and Prospective Validation of the AutoEIT Foundation Model for ARDS
ARDS (Acute Respiratory Distress Syndrome), Respiratory Failure
Recruiting
Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates
Neonatal Resuscitation, Apnea Neonatal
RecruitingObservational study
PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH), Sleep-disordered Breathing (SDB)
Recruiting
Optimal Timing for Spontaneous Breathing Trials
Respiration, Artificial, Weaning
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brijesh Patel, MBBS PhD principal investigator
Royal Brompton & Harefield NHS Foundation Trust
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Beacon Care System in people with Respiration, Artificial and Critical Care, run by Royal Brompton & Harefield NHS Foundation Trust at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Brijesh V Patel, MBBS MRCP FRCA FFICM PhD (+44 (0)20 7352 8121, brijesh.patel@imperial.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Duration of mechanical ventilation (time frame: Until the date of discharge from ICU, up to 12 months.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03697785, which also lists 28 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2018.